Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment (vol 60, pg 23, 2023)

Terzi, Murat, Helvaci, Elif Merve, Sen, Sedat, Boz, Cavit, Cilingir, Vedat, Akcali, Aylin, Beckmann, Yesim, Uzunkopru, Cihat, Turkoglu, Recai, Yuceyar, Nur, Efendi, Huesnue, Bunul, Sena Destan, Seferoglu, Meral, Kotan, Dilcan, Guler, Sibel, Balci, Belgin Petek, Ozturk, Bilgin, Mungan, Semra, Icen, Nilufer Kale, Omerhoca, Sami, Yurtogullari, Sukran, Sevim, Serhan, Turkoglu, Sule Aydin, Cam, Mustafa, Yetkin, Mehmet Fatih, Yoldas, Tahir Kurtulus, Sivaci, Ali Ozhan, Gokce, Seyda Figul, Gursoy, Esra, Unal, Aysun, Bilge, Nuray, Agan, Kadriye, Toprak, Munire Kilinc, Kocer, Belgin, Sozer, Gokce, Terzi, Yuksel